Where is Tensive located?

Tensive is headquartered in Milano, Italy.

How many employees does Tensive have?

As of May 31, 2026, the latest employee count at Tensive is 31.

Is Tensive a funded company?

Tensive is a funded company, having raised a total of $16.7M across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

When was the latest funding round of Tensive?

Tensive's latest funding was a $***** Series A round on Jan 31, 2025, with participation from 0 investor. Its primary sector is Women Health. In Italy, the Women Health sector has seen $23.2M in funding in 2026 to date.

Where does Tensive rank among its competitors?

Tensive ranks 9th amongst 37 active competitors, of which 10 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Lattice Medical, which secured an undisclosed amount in Oct, 2025.

Who are the top competitors of Tensive?

Tensive's top competitors include Establishment Labs, GC Aesthetics and Sientra. Among them, Lattice Medical secured the most recent funding round in October, 2025.

Tensive - 2026 Company Profile, Team, Funding & Competitors

Company Details

Tensive, a spin-off of Fondazione Filarete, is a biomedical company focused on developing innovative prostheses to provide for a natural breast reconstruction or augmentation. Its product is in laboratory testing phase and is not yet tested on humans. Tensive’s technology aims to stimulate the regeneration of natural fat. Its prostheses, not yet tested on humans, are based on synthetic and biodegradable biomaterials which are designed to be gradually degraded and replaced by the patient’s fat tissue once the regeneration is complete.

Key Metrics

Founded Year

2012

Location

Milano, Italy

Stage

Series A

Total Funding

$16.7M in 8 rounds

Latest Funding Round

Series A, Jan 31, 2025, $*****

Investors

UniCredit Start Lab & 4 more

Ranked

9^th among 37 active competitors

Employee Count

31 as on May 31, 2026

Similar Companies

Establishment Labs & 42 more

View Tensive's full profile

Tensive has raised a total funding of $16.7M over 8 rounds. Tensive has 5 institutional investors.

Here is the list of recent funding rounds of Tensive:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 31, 2025	2008798	Series A	8204493	7450960	3316524	2138280
May 31, 2021	7066964	Grant (prize money)	8389351	2337452	5588515	EIC Fund
Jun 01, 2018	1860887	Grant (prize money)	3878223	3415979	9396526	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Tensive's funding rounds and investors

The founders of Tensive is Alessandro Tocchio.

Here are the details of Tensive's key team members:

Alessandro Tocchio: Co-Founder of Tensive and founder of 1 other company.

View details of Tensive's Founder profiles and Board Members

Tensive's employee count trend

Tensive has 31 employees as of May 26. Here is Tensive's employee count trend over the years:

Uncover Tensive's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tensive include Establishment Labs, GC Aesthetics and Sientra. Here is the list of Top 10 competitors of Tensive, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Establishment Labs 2010, Alajuela (Costa Rica), Public	Developer of silicone-filled breast and body shaping implants	$121M	Perceptive Advisors, Crown Predator Holdings ... & 7 others	70/100
2nd	GC Aesthetics 2007, Dublin (Ireland), Series E	Manufacturer of silicone breast implants for aesthetic and reconstructive surgery	$233M	Montreux Equity Partners, Barry’s Tea & 18 others	56/100
3rd	Sientra 2007, Santa Barbara (United States), Public	Products for plastic surgery/ aesthetics	$150M	Goldman Sachs, Deerfield & 4 others	53/100
4th	Healshape 2020, Villeurbanne (France), Series A	Developer of products for breast reconstruction and augmentation	$12.8M	Demeter, GO CAPITAL & 4 others	51/100
5th	Lattice Medical 2017, Loos (France), Series B	Provider of 3D-printed technology for soft tissue reconstruction	$63.4M	EIC Fund, Bpifrance & 8 others	49/100
6th	BellaSeno 2015, Leipzig (Germany), Unfunded	Developer of breast implants	-	-	44/100
7th	BioAesthetics 2015, New Orleans (United States), Series A	Developer of a tissue-engineered nipple-areolar complex	$7.4M	FemHealthVentures, Hemi Ventures & 16 others	42/100
8th	AirXpanders 2006, Mountain View (United States), Public	Tissue exapnder for post mastectomy reconstructive surgery	-	Western Technology Investment, Vivo Capital ... & 8 others	41/100
9th	Tensive 2012, Milano (Italy), Series A	Prostheses for a natural breast reconstruction	$16.7M	Mediobanca, EIC Fund & 3 others	41/100
10th	Ideal Implant 2006, Dallas (United States), Acquired	Medical device and biologics company innovating tissue and cell-based technologies	$17M	CB3 Holdings	41/100